Phase I trials of targeted anticancer drugs: a need to refocus
Author:
Publisher
Springer Science and Business Media LLC
Subject
Drug Discovery,Pharmacology,General Medicine
Link
http://www.nature.com/articles/nrd3909.pdf
Reference5 articles.
1. American Society of Clinical Oncology. 2012 ASCO Annual Meeting Proceedings [online] , (2012).
2. Glassman, R. H. & Ratain, M. J. Biomarkers in early cancer drug development: limited utility. Clin. Pharmacol. Ther. 85, 134–135 (2009).
3. Kummar, S. et al. Phase 0 clinical trials: recommendations from the Task Force on Methodology for the Development of Innovative Cancer Therapies. Eur. J. Cancer 45, 741–746 (2009).
4. Goodwin, R. et al. Targeted agents: how to select winners in preclinical and early clinical studies? Eur. J. Cancer 48, 170–178 (2012).
5. Le Tourneau, C., Lee, J. J. & Siu, L. L. Dose escalation methods in Phase I cancer clinical trials. J. Natl Cancer Inst. 101, 708–720 (2009).
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Discontinued in 2013: oncology drugs;Expert Opinion on Investigational Drugs;2014-10-14
2. The Future of Cancer Clinical Trials Systems;Juntendo Medical Journal;2014
3. Discontinued drugs in 2012: oncology drugs;Expert Opinion on Investigational Drugs;2013-10-08
4. Metrics other than potency reveal systematic variation in responses to cancer drugs;Nature Chemical Biology;2013-09-08
5. Design and conduct of early clinical studies of two or more targeted anticancer therapies: Recommendations from the task force on Methodology for the Development of Innovative Cancer Therapies;European Journal of Cancer;2013-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3